Skip to main content

Closed

HRTX: Heron Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-6.9%

ROIC-6.7%

Financially safe

Stretched

Debt / equity15.50×

Interest coverage-2.7×

Current ratio2.53×

Heron Therapeutics, Inc.

HRTXNASDAQ Capital Market·USD·Closed

Heron Therapeutics, Inc.

HRTXNASDAQ·USD·Closed

$0.50

−0.24%

$0.50

−$0.00 (0.24%)

52W Range

8thpctl

Volume

0.40×avg

Mkt Cap

93.92MUSD

P/E

-2.8TTM

Div Yield

–ann

52W Range

8thpctl

Volume

0.40×avg

Market Cap

93.92MUSD

P/E Ratio

-2.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings